Jacob Ma-Weaver Joins ARCA biopharma Board of Directors
21 Juin 2022 - 10:05PM
ARCA biopharma, Inc. (Nasdaq: ABIO) today announced that Jacob
Ma-Weaver has joined its Board of Directors.
“We are pleased to welcome Jacob Ma-Weaver, the
managing member of ARCA’s largest shareholder, to our Board,” said
Robert E. Conway, Chairman of ARCA’s Board of Directors. “We
appreciate his participation and input as we explore and evaluate
strategic options for maximizing stockholder value.”
Mr. Ma-Weaver is the Managing Member of Cable
Car Capital LLC, an investment adviser he founded in 2013. Cable
Car Capital LLC is the General Partner of The Funicular Fund, LP, a
hedge fund. Since 2013, Mr. Ma-Weaver has been continuously
involved in implementing the firm’s investment approach through the
fund and its predecessor accounts. From 2012 to 2013, Mr. Ma-Weaver
was employed as an investment analyst at Amici Capital LLC, where
he focused on healthcare. He was previously employed as an equity
research associate at Dodge & Cox and a corporate finance
business analyst at McKinsey & Company. Mr. Ma-Weaver received
a Bachelor of Arts in Comparative Literature & Society and
Economics and a Master of Arts in Statistics from Columbia
University. He is a Chartered Financial Analyst (CFA)
charterholder.
The Company has entered into a Cooperation
Agreement with Cable Car Capital LLC and its affiliates that
includes, among other terms, customary standstill provisions and
the right for Cable Car to nominate an additional director nominee
at the Company’s 2022 Annual Stockholder Meeting.
About ARCA biopharmaARCA
biopharma is dedicated to developing genetically and other targeted
therapies for cardiovascular diseases through a precision medicine
approach to drug development. At present, ARCA is evaluating
options for development of its assets, including partnering and
other strategic options. For more information, please visit
www.arcabio.com.
Investor & Media
Contact:Derek Cole720.940.2163derek.cole@arcabio.com
ARCA Biopharma (NASDAQ:ABIO)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
ARCA Biopharma (NASDAQ:ABIO)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024